NO20025149L - Nucleic Acids Encoding a New Regulator of G Protein Signaling, RGS18, and Applications of These - Google Patents

Nucleic Acids Encoding a New Regulator of G Protein Signaling, RGS18, and Applications of These

Info

Publication number
NO20025149L
NO20025149L NO20025149A NO20025149A NO20025149L NO 20025149 L NO20025149 L NO 20025149L NO 20025149 A NO20025149 A NO 20025149A NO 20025149 A NO20025149 A NO 20025149A NO 20025149 L NO20025149 L NO 20025149L
Authority
NO
Norway
Prior art keywords
rgs18
applications
nucleic acids
acids encoding
protein signaling
Prior art date
Application number
NO20025149A
Other languages
Norwegian (no)
Other versions
NO20025149D0 (en
Inventor
David L Murray
Alison W Gagnon
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018833A external-priority patent/GB0018833D0/en
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20025149D0 publication Critical patent/NO20025149D0/en
Publication of NO20025149L publication Critical patent/NO20025149L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20025149A 2000-04-28 2002-10-25 Nucleic Acids Encoding a New Regulator of G Protein Signaling, RGS18, and Applications of These NO20025149L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20078600P 2000-04-28 2000-04-28
GB0018833A GB0018833D0 (en) 2000-08-02 2000-08-02 Nucleic acids and uses thereof
PCT/US2001/013540 WO2001083514A2 (en) 2000-04-28 2001-04-26 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof

Publications (2)

Publication Number Publication Date
NO20025149D0 NO20025149D0 (en) 2002-10-25
NO20025149L true NO20025149L (en) 2002-12-16

Family

ID=26244772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025149A NO20025149L (en) 2000-04-28 2002-10-25 Nucleic Acids Encoding a New Regulator of G Protein Signaling, RGS18, and Applications of These

Country Status (11)

Country Link
EP (1) EP1292616A2 (en)
JP (1) JP2003531631A (en)
KR (1) KR20030064271A (en)
AU (1) AU2001261054A1 (en)
BR (1) BR0110417A (en)
CA (1) CA2408073A1 (en)
IL (1) IL152498A0 (en)
MX (1) MXPA02010414A (en)
NO (1) NO20025149L (en)
NZ (1) NZ522034A (en)
WO (1) WO2001083514A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015708D0 (en) * 2000-06-27 2000-08-16 Smithkline Beecham Plc Novel compounds
US7846671B2 (en) 2002-01-28 2010-12-07 Bristol-Myers Squibb Company Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274362B1 (en) * 1999-02-04 2001-08-14 Millennium Pharmaceuticals, Inc. RGS-containing molecules and uses thereof

Also Published As

Publication number Publication date
MXPA02010414A (en) 2003-04-25
CA2408073A1 (en) 2001-11-08
EP1292616A2 (en) 2003-03-19
AU2001261054A1 (en) 2001-11-12
NZ522034A (en) 2004-08-27
WO2001083514A3 (en) 2002-09-19
BR0110417A (en) 2003-06-03
JP2003531631A (en) 2003-10-28
KR20030064271A (en) 2003-07-31
WO2001083514A2 (en) 2001-11-08
IL152498A0 (en) 2003-05-29
NO20025149D0 (en) 2002-10-25

Similar Documents

Publication Publication Date Title
DK1516053T3 (en) Xylanases, their coding nucleic acids, and processes for their preparation and use
DK1436309T3 (en) Therefore, BGL3 beta-glucosidase and nucleic acids encode
DE60223982D1 (en) Coding of concentric data
DK1309692T3 (en) Anti-IL12 antibodies, preparations, methods and applications
NO20023707L (en) Inverted well service fluid and method
EP1539942A4 (en) Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
AU2002315525A1 (en) Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
AU2002323249A1 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
NO20025149L (en) Nucleic Acids Encoding a New Regulator of G Protein Signaling, RGS18, and Applications of These
EP1383533A4 (en) Proteins and nucleic acids encoding same
EP1383907A4 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002333654A1 (en) Mcfp encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
NO20021614L (en) DNA encoding PROST 07 polypeptide
WO2003031642A3 (en) lovE VARIANT REGULATOR MOLECULES
AU2002256019A8 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
NO20024029L (en) New protein and gene encoding the protein
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1379678A4 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1395674A4 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1383871A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
FR2804690B1 (en) NEW PROTEIN FAMILIES, NAMED ATIP, NUCLEIC SEQUENCES ENCODING SAID PROTEINS AND THEIR APPLICATIONS
EP1383908A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1385991A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application